Showing results (441-450 of 1,005) with videos related to
Sort By:
Pageof 101
Ejhaem|May 2, 2025
Safe and Efficacious Use of Low-Dose Rituximab in Postpubertal Paediatric Patients With Immune ThrombocytopeniaJennifer Darlow, Gerard Gurumurthy, Nathan Jeffreys, et al.Ejhaem|April 25, 2025
Immune Thrombocytopenia in an Adult With X-linked Agammaglobulinemia: A Case ReportTakeaki Matsunaga, Ken Naganuma, Noriko Tanabe, et al.Ejhaem|April 28, 2025
Enhanced Disease Detection of Hairy Cell Leukaemia Through Next-Generation Sequencing Based BRAF V600E and Phased Variant AnalysisSimon Wu, Tamia Nguyen, Imogen Caldwell, et al.Ejhaem|March 31, 2025
The Effect of COVID-19 on Platelet Counts in Persistent and Chronic Adult ITP Patients: A Real-World Study in ChinaYujiao Zhang, Lei Yang, Zhongping Xu, et al.Ejhaem|March 7, 2025
Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case reportSatoshi Mitsuyuki, Sayaka Okazaki, Satoru Mukai, et al.Ejhaem|March 24, 2025
Real World Management of Cytopenias and Infections in Patients With Myelofibrosis Treated With RuxolitinibLiesl A Butler, Cecily Forsyth, Claire Harrison, et al.Ejhaem|March 24, 2025
EPYSQLI (SB12; Biosimilar to Reference Eculizumab) in Asian and Non-Asian Patients With Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled TrialJun Ho Jang, Ciprian Tomuleasa, Hanna Oliynyk, et al.Ejhaem|June 19, 2024
The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patientsLjupco Veskovski, Ingvar Jakobsson, Per-Ola Andersson, et al.Ejhaem|June 19, 2024
Eculizumab for Shiga-toxin-induced hemolytic uremic syndrome in adults with neurological involvementBenjamin J Lee, Zhaohui Arter, Jean Doh, et al.Ejhaem|June 19, 2024
Red blood cell distribution width is a useful biomarker to predict bleeding and thrombosis risks in patients with immune thrombocytopenic purpuraNaokazu Nakamura, Hiroko Tsunemine, Ryo Ikunari, et al.Pageof 101